Atomic Invest’s Eli Lilly LLY Stock Holding History

Atomic Invest’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.9K	Sell	49 -3	-6%	-$3.06K	0.01%	112
2026 Q1	$46.5K	Buy	52 +6	+13%	+$6.08K	0.02%	111
2025 Q4	$49.5K	Buy	+46	New	+$44K	0.03%	83

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atomic Invest's LLY Position: Q2 2026 in Review

Atomic Invest reduced its Eli Lilly (LLY) stake by 5.8% in Q2 2026, selling an estimated $3.06K and leaving 49 shares worth $59.9K. The position accounts for 0.01% of the portfolio, ranked #112.

Atomic Invest first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,641 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Atomic Invest held 49 shares of Eli Lilly worth $59.9K as of Q2 2026.
Atomic Invest sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
Eli Lilly made up 0.01% of Atomic Invest's portfolio in Q2 2026, its #112 holding.
Atomic Invest first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
4,641 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Atomic Invest's 13F filing for Q2 2026, filed 25 Sep 2026.